Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €63.90 EUR
Change Today +1.90 / 3.06%
Volume 19.9K
NRX On Other Exchanges
EN Paris
As of 11:35 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

naturex (NRX) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/10/14 - €68.70
52 Week Low
11/14/14 - €43.62
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NATUREX (NRX)

Related News

No related news articles were found.

naturex (NRX) Related Businessweek News

No Related Businessweek News Found

naturex (NRX) Details

Naturex S.A. manufactures and sells natural specialty ingredients for the food and beverage, nutrition and health, and personal care industries worldwide. Its products include NAT stabil, which is a natural ingredient for food preservation; NAT arom, a palette of plant extracts, oleoresins, and essential oils for flavor, food, and beverage manufacturers; NAT color, a range of colors ingredients; NAT healthy, a line of botanical extracts; NAT textur, a range of pectins that offers a palette of texturizing sensations covering various applications, such as jams, fruit spreads, fruit preparations for baked and diary products, confectionery, beverages, glazings, and desserts; NAT F&V, a range of ingredients that can be applied to various food applications, including baby food, beverages, chocolate, and bakery products; and NAT taste, a range of ingredients that enhance taste of food and beverage products. The company also provides NAT life, a line of branded ingredient concepts for use in dietary supplements, functional foods, and nutraceuticals; NAT active, a line of botanical extracts for the dietary supplements and nutraceutical products; and NAT pharma, a range of active pharmaceutical ingredients. In addition, it offers NAT oleis, a range of botanicals oils; NAT beauty, a range of active ingredients for personal care applications; and NAT select, which is a collection of botanical extracts for use in cosmetics. Naturex S.A. was founded in 1992 and is headquartered in Avignon, France.

1,718 Employees
Last Reported Date: 04/30/15
Founded in 1992

naturex (NRX) Top Compensated Officers

Chief Operating Officer of America/Asia Pacif...
Total Annual Compensation: €434.0K
Compensation as of Fiscal Year 2013.

naturex (NRX) Key Developments

Naturex Reports Unaudited Consolidated Revenue Results for the First-Quarter Ended March 31, 2015

Naturex reported unaudited consolidated revenue results for the first-quarter ended March 31, 2015. For the period, the company reported revenue of €98,602,000 compared to €79,603,000 a year ago. Consolidated revenue for the 2015 first quarter rose to €98.6 million, with particularly robust growth of 23.9%, compared to last year's same period.

Naturex Announces Management Changes

Naturex's Board of Directors, meeting on March 31, 2015, duly noted, after having indicated his wish to retire, Thierry Lambert's resignation with immediate effect from the offices of Director and Chairman of the Board of Directors. In addition, Olivier Rigaud, also announced the departure of Thierry-Bertrand Lambert who has served as Chief Financial Officer since January 2013.

Naturex Reports Consolidated Earnings Results for the Year Ended December 31, 2014

Naturex reported consolidated earnings results for the year ended December 31, 2014. For the year, the company reported net loss attributable to the group of €4.1 million on revenues of €327.3 million compared to profit of €16.8 million on revenues of €320.8 million a year ago. Current operating income was €14.8 million compared to €35.3 million a year ago. Recurring EBITDA was €36.8 million compared to €53.0 million a year ago. Net operating income was €7.7 million compared to €34.5 million a year ago. Operating income after equity-accounted investees was €6.8 million compared to €34.4 million a year ago. Loss before tax was €2.0 million compared to €25.9 million a year ago. Performances in 2014 were adversely affected by several macroeconomic and geopolitical factors, further exacerbated by highly volatile foreign exchange trends over the first nine months. In addition, Group results were impacted by difficult market conditions for some of its historic positions (the Food & Beverage business in Europe and Nutrition & Health in the United States) as well as a negative comparison base from Svetol® sales in the US (€7.6 million) and krill extraction sales (€8.8 million). At December 31, 2014, net financial debt totaled €160.3 million.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NRX:FP €63.90 EUR +1.90

NRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NRX.
View Industry Companies

Industry Analysis


Industry Average

Valuation NRX Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NATUREX, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at